PT  - JOURNAL ARTICLE
AU  - Jennifer L. Cleary
AU  - Yu Fang
AU  - Srijan Sen
AU  - Zhenke Wu
TI  - A Caveat to Using Wearable Sensor Data for COVID-19 Detection: The Role of Behavioral Change after Receipt of Test Results
AID  - 10.1101/2021.04.17.21255513
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.17.21255513
4099  - http://medrxiv.org/content/early/2021/04/22/2021.04.17.21255513.short
4100  - http://medrxiv.org/content/early/2021/04/22/2021.04.17.21255513.full
AB  - Recent studies indicate that wearable sensors have the potential to capture subtle within-person changes that signal SARS-CoV-2 infection. However, it remains unclear the extent to which observed discriminative performance is attributable to behavioral change after receiving test results. We conducted a retrospective study in a sample of medical interns who received COVID-19 test results from March to December 2020. Our data confirmed that sensor data were able to differentiate between symptomatic COVID-19 positive and negative individuals with good accuracy (area under the curve (AUC) = 0.75). However, removing post-result data substantially reduced discriminative capacity (0.75 to 0.63; delta= −0.12, p=0.013). Removing data in the symptomatic period prior to receipt of test results did not produce similar reductions in discriminative capacity. These findings suggest a meaningful proportion of the discriminative capacity of wearable sensor data for SARS-CoV-2 infection may be due to behavior change after receiving test results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from the National Institute of Mental Health (R01 MH101459) to S.S. and Z.W. and an investigator grant from Precision Health Initiative at University of Michigan, Ann Arbor to Z.W. and S.S.. J.C. was supported by T32HD007109.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB, University of Michigan, Ann ArborAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for replication the results in the paper is available upon reasonable request.